TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc., trading under the ticker MTAC, is a medical technology company focused on oncology drug delivery that completed its business combination with MedTech Acquisition Corp, a SPAC sponsored by MedTech Acquisition Sponsor LLC, which held its IPO in 2021. The company operates in the healthcare and life sciences sector, developing interventional oncology platforms targeting liver and pancreatic cancers. On May 12, 2026, TriSalus filed an 8-K current report with the SEC under accession number 0001628280-26-034082, disclosing a material event as required under Exchange Act reporting obligations. For complete filing history, deal terms, and ongoing status data on MTAC and thousands of other SPAC transactions, sign up for full access at SpacDesk.